A sustained activation of PI3K/NF-κB pathway is critical for the survival of chronic lymphocytic leukemia B cells

被引:215
作者
Cuní, S
Pérez-Aciego, P
Pérez-Chacón, G
Vargas, JA
Sánchez, A
Martín-Saavedra, FM
Ballester, S
García-Marco, J
Jordá, J
Durántez, A
机构
[1] Fdn LAIR, E-28050 Madrid, Spain
[2] Hop Univ Puerta Hierro, Serv Med Interna 1, Madrid, Spain
[3] Hop Univ Puerta Hierro, Serv Neuroimmunol, Madrid, Spain
[4] Inst Salud Carlos III, Unidad Regulac Gen, Madrid, Spain
[5] Hosp Univ Puerta Hierro, Serv Hematol, Madrid, Spain
[6] Hosp Clin Univ San Carlos, Serv Hematol, Madrid, Spain
关键词
B-cell chronic lymphocytic leukemia; cell signaling; PI3K pathway; NF-kappa B activity; Akt; Bcl-x(L) expression;
D O I
10.1038/sj.leu.2403398
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The progressive rise of mature CD5(+) B lymphocytes, despite the low proportion of proliferating cells, has led to the notion that B cell chronic lymphocytic leukemia (B-CLL) is primarily related to defective apoptosis. The microenvironment likely plays a prominent role because the malignant cells progressively accumulate in vivo, whereas they rapidly undergo spontaneous apoptosis when cultured in vitro. To assess microenvironment-mediated survival signals, B-CLL cells were cultured with a murine fibroblast cell line, Ltk(-), with and without an agonistic antibody to CD40. Spontaneous apoptosis was associated with the loss of Akt and NF-kappaB activities. Interactions with fibroblasts sustained a basal level of Akt and NF-kappaB activities, which was dependent on phosphatidylinositol-3 kinase (PI3K). Constitutive activity of the PI3K pathway in B-CLL cells when cultured with fibroblasts prevented the down-regulation of the prosurvival Bcl-2 family protein Bcl-x(L) and the caspase inhibitor proteins FLIPL and XIAP, and consequently caspase-3 activation and apoptosis. CD40 crosslinking in B-CLL cells did not further prevent murine fibroblasts-mediated apoptosis but induced cell proliferation, which was associated with an increase of Akt and NF-kappaB activation compared with cells cultured with fibroblasts alone. The PI3K pathway seems to play a pivotal role in B-CLL cell survival and growth.
引用
收藏
页码:1391 / 1400
页数:10
相关论文
共 68 条
[1]   Proteasome inhibition: a new strategy in cancer treatment [J].
Adams, J ;
Palombella, VJ ;
Elliott, PJ .
INVESTIGATIONAL NEW DRUGS, 2000, 18 (02) :109-121
[2]   Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase [J].
Ahmed, NN ;
Grimes, HL ;
Bellacosa, A ;
Chan, TO ;
Tsichlis, PN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :3627-3632
[3]   Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha [J].
Alessi, DR ;
James, SR ;
Downes, CP ;
Holmes, AB ;
Gaffney, PRJ ;
Reese, CB ;
Cohen, P .
CURRENT BIOLOGY, 1997, 7 (04) :261-269
[4]   LONG-TERM HUMAN B-CELL LINES DEPENDENT ON INTERLEUKIN-4 AND ANTIBODY TO CD40 [J].
BANCHEREAU, J ;
DEPAOLI, P ;
VALLE, A ;
GARCIA, E ;
ROUSSET, F .
SCIENCE, 1991, 251 (4989) :70-72
[5]   THE CD40 ANTIGEN AND ITS LIGAND [J].
BANCHEREAU, J ;
BAZAN, F ;
BLANCHARD, D ;
BRIERE, F ;
GALIZZI, JP ;
VANKOOTEN, C ;
LIU, YJ ;
ROUSSET, F ;
SAELAND, S .
ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 :881-922
[6]   Update on the biology of chronic lymphocytic leukemia [J].
Bannerji, R ;
Byrd, JC .
CURRENT OPINION IN ONCOLOGY, 2000, 12 (01) :22-29
[7]   Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-κB activation [J].
Béraud, C ;
Henzel, WJ ;
Baeuerle, PA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (02) :429-434
[8]   Survival of leukemic B cells promoted by engagement of the antigen receptor [J].
Bernal, A ;
Pastore, RD ;
Asgary, Z ;
Keller, SA ;
Cesarman, E ;
Liou, HC ;
Schattner, EJ .
BLOOD, 2001, 98 (10) :3050-3057
[9]   The activation of p38 and apoptosis by the inhibition of ERK is antagonized by the phosphoinositide S-kinase/Akt pathway [J].
Berra, E ;
Diaz-Meco, MT ;
Moscat, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (17) :10792-10797
[10]  
Burger JA, 2000, BLOOD, V96, P2655